Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

Cindy Serdjebi; Jean-François Seitz; Joseph Ciccolini; Muriel Duluc; Emmanuelle Norguet; Frédéric Fina; Bruno Lacarelle; L’houcine Ouafik; Laetitia Dahan

doi:10.2217/pgs.13.93

Journal articles

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

Cindy Serdjebi ¹ Jean-François Seitz ² Joseph Ciccolini ^{3, 1} Muriel Duluc ² Emmanuelle Norguet ² Frédéric Fina ⁴ Bruno Lacarelle ^{5, 1} L’houcine Ouafik ^{1, 4} Laetitia Dahan ^{6, 2}

1 CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie

2 Service d'oncologie digestive et hépato-gastro-entérologie [Hôpital de la Timone - APHM]

3 SMARTc

CRO2 - Centre de Recherches en Oncologie biologique et Oncopharmacologie

4 Laboratoire de Transfert d'Oncologie Biologique [Hôpital Nord - APHM]

5 Pharmacocinétique Toxicocinétique - [Hôpital de la Timone - APHM]

6 TIMONE - Hôpital de la Timone [CHU - APHM]

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Cancer

Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-01708020
Contributor : l'Houcine Ouafik <>
Submitted on : Tuesday, February 13, 2018 - 11:52:49 AM
Last modification on : Wednesday, August 19, 2020 - 12:08:25 PM

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

Identifiers

Collections

Citation

Export

Metrics

114

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

Identifiers

Collections

Citation

Export

Share

Metrics

114